Phospho-CDK1/2 (Thr14) Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-61198r-100uL |
| Product Name | Phospho-CDK1/2 (Thr14) Recombinant Antibody |
| Applications |
WB
IHC-P
IHC-F
IF(IHC-P)
IP
|
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human CDK1 around the phosphorylation site of T14 |
| Modification Site | Thr14 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 983 |
| Swiss Prot | P06493,P24941 |
| Subcellular location | Cytoplasm, Nucleus |
| Synonyms | CDC28; CDC2A; CDK1; Cell division control protein 2 homolog; Cyclin-dependent kinase 1; MPF; kinase Cdc2; p34 protein kinase. |
| Background | Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition via association with multiple interphase. |
| Application Dilution | |
| WB | 1:1000-2000 |
| IHC-P | IHC-P1:100-500 |
| IHC-F | IHC-F1:100-500 |
| IF(IHC-P) | IFIHC-P1:100-500 |
| IP | IP1:20-50 |
Frequently asked questions
Which applications is Phospho-CDK1/2 (Thr14) Recombinant Antibody (bsm-61198R) validated for, and at what dilution?
bsm-61198R is validated for WB(WB) (1:1000-2000); IHC-P(IHC-P) (1:100-500); IHC-F(IHC-F) (1:100-500); IF(IHC-P)(IF(IHC-P)) (1:100-500); IP(IP) (1:20-50). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does Phospho-CDK1/2 (Thr14) Recombinant Antibody (bsm-61198R) react with?
Tested reactivity: Human, Mouse, Rat.
How should bsm-61198R be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
What immunogen was used to raise Phospho-CDK1/2 (Thr14) Recombinant Antibody (bsm-61198R)?
KLH conjugated synthetic peptide derived from human CDK1 around the phosphorylation site of T14
